HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
26 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
KRT14
keratin 14
Chromosome 17 Β· 17q21.2
NCBI Gene: 3861Ensembl: ENSG00000186847.6HGNC: HGNC:6416UniProt: P02533
254PubMed Papers
26Diseases
0Drugs
76Pathogenic Variants
RESEARCH IMPACT
TrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingextracellular exosomekeratin filament bindinghair cycleepidermolysis bullosa simplex 1A, generalized severeepidermolysis bullosa simplex 1C, localizedNaegeli-Franceschetti-Jadassohn syndromeepidermolysis bullosa simplex 1B, generalized intermediate
✦AI Summary

KRT14 (keratin 14) is a structural intermediate filament protein predominantly expressed in basal layer keratinocytes and other stratified epithelia. 1 Its primary function involves assembling with KRT5 to form the basal cytoskeletal network that provides mechanical resilience to epithelial tissues. 2 KRT14-KRT5 heterodimers are restricted to proliferative basal cells, while their expression is downregulated during keratinocyte differentiation when KRT10-KRT1 becomes predominant. 2 KRT14 contributes to both normal epithelial homeostasis and pathological processes. In wound healing and diabetic ulcers, KRT14+ keratinocytes serve as markers of basal proliferative cells undergoing repair. 3 Beyond structural roles, KRT14 has emerged as a functional player in disease progression: elevated KRT14 expression driven by EZH2-H3K27me3 signaling promotes triple-negative breast cancer peritoneal metastasis through enhanced cell migration and invasion. 4 Additionally, keratinocyte-specific KRT14-driven expression systems reveal that KRT14+ cells regulate inflammatory responses, particularly through HMGB1-associated autophagy in psoriasis pathogenesis. 5 Mutations in KRT14 cause epidermolysis bullosa simplex (EBS), a blistering disorder affecting approximately 6-30 per million births, arising from impaired cytoskeletal integrity in basal keratinocytes. 6 KRT14 also marks specialized progenitor populations in bone regeneration and thymic tumors, suggesting broader developmental roles beyond traditional epithelial functions.

Sources cited
1
EZH2-H3K27me3-mediated KRT14 upregulation promotes TNBC migration, invasion, and peritoneal metastasis
PMID: 36446780
2
KRT14-driven keratinocyte-specific autophagy and HMGB1 secretion regulate psoriatic inflammation
PMID: 32019420
3
KRT14-KRT5 expression is restricted to basal proliferative keratinocytes and is downregulated upon differentiation
PMID: 31374826
4
KRT5 and KRT14 are expressed in basal cells that serve as stem/progenitor cells in airway epithelium
PMID: 19625615
5
KRT14 mutations cause epidermolysis bullosa simplex through impaired basal layer cytoskeletal integrity
PMID: 19945613
6
KRT14+ keratinocytes are markers of basal proliferative cells involved in wound healing and re-epithelialization
PMID: 39923118
7
KRT14+Ctsk+ cells represent a novel osteoprogenitor population with epithelial-mesenchymal properties in bone regeneration
PMID: 35821090
8
KRT14 expression marks medullary thymic epithelial cell phenotype in thymic epithelial tumors
PMID: 36115836
Disease Associationsβ“˜26
epidermolysis bullosa simplex 1A, generalized severeOpen Targets
0.81Strong
epidermolysis bullosa simplex 1C, localizedOpen Targets
0.81Strong
Naegeli-Franceschetti-Jadassohn syndromeOpen Targets
0.76Strong
epidermolysis bullosa simplex 1B, generalized intermediateOpen Targets
0.75Strong
dermatopathia pigmentosa reticularisOpen Targets
0.75Strong
epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessiveOpen Targets
0.75Strong
Epidermolysis bullosa simplex, Dowling-Meara typeOpen Targets
0.73Strong
Localized epidermolysis bullosa simplexOpen Targets
0.70Strong
Generalized epidermolysis bullosa simplex, non-Dowling-Meara typeOpen Targets
0.70Moderate
epidermolysis bullosa simplexOpen Targets
0.64Moderate
KRT14-related epidermolysis bullosa simplexOpen Targets
0.60Moderate
genetic disorderOpen Targets
0.41Moderate
epidermolysis bullosaOpen Targets
0.40Moderate
Palmoplantar keratodermaOpen Targets
0.37Weak
epidermolysis bullosa simplex 2F, with mottled pigmentationOpen Targets
0.37Weak
Epidermolysis bullosa simplex with mottled pigmentationOpen Targets
0.37Weak
Abnormality of the skinOpen Targets
0.34Weak
Palmoplantar blisteringOpen Targets
0.34Weak
Skin fragility with non-scarring blisteringOpen Targets
0.34Weak
SjΓΆgren-Larsson syndromeOpen Targets
0.26Weak
Dermatopathia pigmentosa reticularisUniProt
Epidermolysis bullosa simplex 1A, generalized severeUniProt
Epidermolysis bullosa simplex 1B, generalized intermediateUniProt
Epidermolysis bullosa simplex 1C, localizedUniProt
Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessiveUniProt
Naegeli-Franceschetti-Jadassohn syndromeUniProt
Pathogenic Variants76
NM_000526.5(KRT14):c.374G>A (p.Arg125His)Pathogenic
Epidermolysis bullosa simplex 1A, generalized severe|not provided|Dermatopathia pigmentosa reticularis|KRT14-related disorder|Epidermolysis bullosa simplex, Koebner type
β˜…β˜…β˜†β˜†2026β†’ Residue 125
NM_000526.5(KRT14):c.373C>T (p.Arg125Cys)Pathogenic
Epidermolysis bullosa simplex 1A, generalized severe|not provided|Epidermolysis bullosa simplex|Epidermolysis bullosa simplex, Koebner type;Epidermolysis bullosa simplex 1A, generalized severe|KRT14-related disorder|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 125
NM_000526.5(KRT14):c.915G>A (p.Trp305Ter)Pathogenic
not provided|Epidermolysis bullosa simplex 1A, generalized severe|Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive
β˜…β˜…β˜†β˜†2025β†’ Residue 305
NM_000526.5(KRT14):c.1163G>A (p.Arg388His)Likely pathogenic
not provided|6 conditions
β˜…β˜…β˜†β˜†2025β†’ Residue 388
NM_000526.5(KRT14):c.1162C>T (p.Arg388Cys)Pathogenic
not provided|Palmoplantar blistering;Skin fragility with non-scarring blistering
β˜…β˜…β˜†β˜†2025β†’ Residue 388
NM_000526.5(KRT14):c.1130T>C (p.Ile377Thr)Pathogenic
not provided|Epidermolysis bullosa simplex 1C, localized
β˜…β˜…β˜†β˜†2025β†’ Residue 377
NM_000526.5(KRT14):c.863G>T (p.Arg288Leu)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 288
NM_000526.5(KRT14):c.526-2A>CLikely pathogenic
Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive|not provided|6 conditions
β˜…β˜…β˜†β˜†2025
NM_000526.5(KRT14):c.815T>C (p.Met272Thr)Pathogenic
not provided|Epidermolysis bullosa simplex|Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive
β˜…β˜…β˜†β˜†2025β†’ Residue 272
NM_000526.5(KRT14):c.1151T>C (p.Leu384Pro)Likely pathogenic
Epidermolysis bullosa simplex, Koebner type|not provided|Epidermolysis bullosa simplex 1A, generalized severe
β˜…β˜…β˜†β˜†2025β†’ Residue 384
NM_000526.5(KRT14):c.927+1G>APathogenic
not provided
β˜…β˜…β˜†β˜†2024
NM_000526.5(KRT14):c.356T>C (p.Met119Thr)Pathogenic
Epidermolysis bullosa simplex 1A, generalized severe|not provided|KRT14-related disorder
β˜…β˜…β˜†β˜†2023β†’ Residue 119
NM_000526.5(KRT14):c.397G>T (p.Val133Leu)Pathogenic
not provided|Epidermolysis bullosa simplex
β˜…β˜…β˜†β˜†2022β†’ Residue 133
NM_000526.5(KRT14):c.355A>G (p.Met119Val)Pathogenic
not provided|Epidermolysis bullosa simplex, Koebner type|Dermatopathia pigmentosa reticularis
β˜…β˜…β˜†β˜†2022β†’ Residue 119
NM_000526.5(KRT14):c.374G>T (p.Arg125Leu)Pathogenic
not provided
β˜…β˜…β˜†β˜†2022β†’ Residue 125
NM_000526.5(KRT14):c.766G>T (p.Glu256Ter)Pathogenic
Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive
β˜…β˜…β˜†β˜†2022β†’ Residue 256
NM_000526.5(KRT14):c.92del (p.Ile31fs)Pathogenic
Epidermolysis bullosa simplex 1D, generalized, intermediate or severe, autosomal recessive|not provided|SjΓΆgren-Larsson syndrome|Abnormality of the skin
β˜…β˜…β˜†β˜†2022β†’ Residue 31
NM_000526.5(KRT14):c.397G>A (p.Val133Met)Pathogenic
not provided
β˜…β˜…β˜†β˜†2017β†’ Residue 133
NM_000526.5(KRT14):c.380CCT[1] (p.Ser128del)Pathogenic
not provided
β˜…β˜†β˜†β˜†2026β†’ Residue 128
NM_000526.5(KRT14):c.364C>G (p.Leu122Val)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 122
View on ClinVar β†—
Related Genes
PLECProtein interaction85%COL17A1Protein interaction84%KRT6BProtein interaction84%KRT17Protein interaction81%TP63Protein interaction79%DSG3Protein interaction78%
Tissue Expression6 tissues
Liver
100%
Bone Marrow
79%
Lung
62%
Ovary
50%
Heart
3%
Brain
2%
Gene Interaction Network
Click a node to explore
KRT14PLECCOL17A1KRT6BKRT17TP63DSG3
PROTEIN STRUCTURE
Preparing viewer…
PDB6JFV Β· 2.60 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.93LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.69 [0.51–0.93]
RankingsWhere KRT14 stands among ~20K protein-coding genes
  • #1,514of 20,598
    Most Researched254 Β· top 10%
  • #969of 5,498
    Most Pathogenic Variants76 Β· top quartile
  • #8,611of 17,882
    Most Constrained (LOEUF)0.93
Genes detectedKRT14
Sources retrieved26 papers
Response timeβ€”
πŸ“„ Sources
26β–Ό
1
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis.
PMID: 36446780
Nat Commun Β· 2022
1.00
2
Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation.
PMID: 32019420
Autophagy Β· 2021
0.90
3
Keratin 6, 16 and 17-Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis.
PMID: 31374826
Cells Β· 2019
0.80
4
Basal cells as stem cells of the mouse trachea and human airway epithelium.
PMID: 19625615
Proc Natl Acad Sci U S A Β· 2009
0.70
5
Keratins and epidermolysis bullosa simplex.
PMID: 30078200
J Cell Physiol Β· 2018
0.68